Semaglutide TFA
Semaglutide TFA is a GLP-1 receptor agonist used in research for type 2 diabetes and obesity. It promotes weight loss, improves glycemic control, and reduces cardiovascular risk, with transient GI effects as common side effects. This analog is applicable in both in vitro binding assays and in vivo metabolic disease models.
Product Specifications
Product Name Alternative
910463-68-2, 910463-68-2 free base, GLP-1 receptor, GlucagonReceptor, Glucagon Receptor, Semaglutide TFA, Semaglutide TFA (910463 68 2 free base), Semaglutide TFA (910463682 free base), Semaglutide TFA (910463-68-2 free base)
Field of Research
Immunology & Inflammation; Pharmacology & Drug Discovery, Pharmacology & Drug Discovery
Purity
99.69% (May vary between batches)
Solubility
DMSO:80 mg/mL (18.93 mM) ; H2O:80 mg/mL (18.93 mM)
Smiles
CC[C@@H] ([C@@H] (C (N[C@H] (C (N[C@H] (C (N[C@H] (C (N[C@H] (C (N[C@H] (C (NCC (N[C@H] (C (NCC (O) =O) =O) CCCNC (N) =N) =O) =O) CCCNC (N) =N) =O) C (C) C) =O) CC (C) C) =O) Cc (cn1) c2c1cccc2) =O) C) =O) NC ([C@@H] (NC ([C@@H] (NC ([C@@H] (NC ([C@@H] (NC ([C@@H] (NC ([C@@H] (NC (CNC ([C@@H] (NC ([C@@H] (NC ([C@@H] (NC ([C@@H] (NC ([C@@H] (NC ([C@H] (C (C) C) NC ([C@@H] (NC ([C@@H] (NC ([C@H] ([C@H] (O) C) NC ([C@@H] (NC ([C@H] ([C@H] (O) C) NC (CNC ([C@@H] (NC (C (C) (NC ([C@H] (Cc3ncnc3) N) =O) C) =O) CCC (O) =O) =O) =O) =O) Cc4ccccc4) =O) =O) CO) =O) CC (O) =O) =O) =O) CO) =O) CO) =O) Cc5ccc (O) cc5) =O) CC (C) C) =O) CCC (O) =O) =O) =O) CCC (N) =O) =O) C) =O) C) =O) CCCCNC (COCCOCCNC (COCCOCCNC (CC[C@H] (C (O) =O) NC (CCCCCCCCCCCCCCCCC (O) =O) =O) =O) =O) =O) =O) CCC (O) =O) =O) Cc6ccccc6) =O) C.OC (C (F) (F) F) =O
Molecular Formula
C189H290F3N45O61
Molecular Weight
4225.6482
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog